Furumoto H
Department of Neurology, Kawatetsu Chiba Hospital, Chuo-ku, Chiba-shi, Chiba, Japan.
Eur J Neurol. 2004 Aug;11(8):535-40. doi: 10.1111/j.1468-1331.2004.00827.x.
To investigate the prevalence and severity of excessive daytime somnolence (EDS) in Japanese patients with Parkinson's disease (PD) and to examine the main cause of EDS. Fifty-three Japanese patients with PD (PDs: 32 females and 21 males) and 17 controls (10 females and seven males) were evaluated using the Epworth Sleepiness Scale (ESS). The severity of the disease was evaluated by Unified Parkinson's disease Rating Scale (UPDRS), and information about quality and quantity of medications was collected. The correlations amongst EDS and age, severity of PD, duration of illness and medications were analyzed. The mean ESS score was significantly higher in advanced PDs than in controls, and correlated with the UPDRS score (r(s) = 0.743, P < 0.0001). Age, duration of illness and the dose of levodopa weakly correlated with ESS score. The intake of dopamine agonists did not affect the severity of EDS. The mean ESS score in PDs was lower than that reported in PD in European and American studies. EDS in Japanese patients with PD was milder compared with Caucasian patients, which might be due to the lower doses of the medications used in Japan. The results suggest that EDS in PD is mainly because of neuropathological changes of the disease itself.
为调查日本帕金森病(PD)患者日间过度嗜睡(EDS)的患病率及严重程度,并探究EDS的主要原因。使用爱泼华嗜睡量表(ESS)对53例日本PD患者(32例女性,21例男性)和17名对照者(10例女性,7例男性)进行评估。采用统一帕金森病评定量表(UPDRS)评估疾病严重程度,并收集药物质量和数量的信息。分析EDS与年龄、PD严重程度、病程及药物之间的相关性。晚期PD患者的ESS平均得分显著高于对照者,且与UPDRS评分相关(r(s)=0.743,P<0.0001)。年龄、病程和左旋多巴剂量与ESS评分呈弱相关。多巴胺激动剂的摄入不影响EDS的严重程度。PD患者的ESS平均得分低于欧美研究报道的PD患者。与白种人患者相比,日本PD患者的EDS较轻,这可能是由于日本使用的药物剂量较低。结果表明,PD患者的EDS主要是由于疾病本身的神经病理改变。